Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation

NCT05243303 is registered in ClinicalTrials.gov with Burrell College of Health Sciences as lead sponsor.

NCT NCT05243303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05243303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation
Lead sponsor
Burrell College of Health Sciences
Phase
Not applicable
Overall status
Unknown status
Start date
April 26, 2022
Completion date
February 28, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris